Word count: 3288
Introduction
described in this study not previously associated with COPD, one was a cis-eQTL in lung -136 rs55706246 near LINC00310 was in modest LD (r 2 = 0.24) with rs2834438, an eQTL for KCNE2
137
(p = 3.1x10 -7 )(33). Using GWAS3D, the top-scoring variant at the DLC1 locus was rs58863591,
138
which had active enhancer marks (H3K4me1 and DNase hypersensitivity) and potential long-139 range interactions upstream of DLC1 and near SENP2(34).
140
We also sought to determine whether the group of top (most significant) markers for each 141 analysis (P < 1x10 -6 ) could yield to insights about cell types based on regulatory data 142 ENCODE(35). In the emphysema analysis, cell type enhancer enrichment from analysis of CD14+ monocytes (P = 0.04).
151
We also sought to determine whether our results were consistent with a set of genes more The sign associated with the P-values denotes whether the direction of association is consistent with the direction for COPD (increase in %LAA-950, Pi10, wall area percent, or gas trapping; decrease in Perc15). In Table 3b , results are grouped by whether the smaller directional P-value was found in emphysema phenotypes (top) or airway-related phenotypes (bottom). Genome-wide significant loci from Table 2 (e.g. HHIP) are not included here. All refers to all subjects, case refers to all cases (GOLD 1-4 or 2-4). 
Figures
Figure 1: Local association plots for genome-wide significant loci. a-e) %LAA-950, f) wall area percent, g) % gas trapping.
• Recombination rate (cM/Mb) Recombination rate (cM/Mb) Recombination rate (cM/Mb) Recombination rate (cM/Mb) 
29
Details of the ECLIPSE study have been previously published(1).
30
Genotyping was performed using the Illumina HumanHap 550 V3 (Illumina, San Diego, CA),
31
and BeadStudio quality control, including reclustering on project samples was performed 32 following Illumina guidelines. Quality control was performed using Python (www.python.org) 33 and R (www.r-project.org) scripts in conjunction with plink (v1.05). Subjects and markers with 34 a call rate of < 95% were excluded. Population stratification exclusion and adjustment on self-35 reported white subjects was performed using EIGENSOFT Version 2.0. Details of the 36 genotyping and previous genome-wide association have been published (2) . Imputation was 37 updated using MaCH and minimac with the 1000 Genomes Phase I v3 EUR reference panel as Low-dose (120kVp and 40mAs) CT scans were performed at baseline, 1 year, and 3 year time 40 points; baseline scans were used for the current analysis. All scans were performed using 41 multidetector CT scans (GE Healthcare, Milwaukee, Wis. or Siemens Healthcare, Erlangen, using the third (segmental) to fifth generation airways (4, 5) . Wall area percent was calculated 48 using the mean value of measurements for selected segmental airways (the same as used for
49
COPDGene below) across all lobes. spirometry. Subjects with severe alpha-1 antitrypsin deficiency and other lung diseases (aside 74 from asthma) were excluded. Details of the GenKOLS study have been previously published(7).
75
Genotyping was performed using Illumina HumanHap 550 arrays (Illumina, San Diego, CA),
76
with quality control, population stratification adjustment, and imputation procedures as described 77 previously. A separate set of principal components was calculated for the subset of subjects with 78 CT imaging data. Imputation was updated using MaCH and minimac with the 1000 Genomes High-resolution CT chest scans were performed on a subset of the cohort using a GE LightSpeed 81 Ultra. A low spatial frequency reconstruction algorithm was used for density measurements, and 
97
CT chest imaging was performed on all subjects using a standardized protocol (9) . Quantitative including the lingula; the mean value across all lobes was used for analysis. Details of the 106 imaging techniques have been described previously (10) .
Additional Genetic Analysis Methods

108
Imputed genotypes were included for analysis if they had an Rsq of 0.3 or greater. Individual 109 genetic variants were included in the meta-analysis if they were missing in no more than one 110 study (except for gas trapping, where the variant was required to be present in both COPDGene 111 populations); variants with minor allele frequency < 1% overall or < 0.5% in individual studies 112 were excluded, resulting in 6.9 (gas trapping) to 7.6 million (all other phenotypes) total analyzed 113 variants. All variants were oriented to the '+' strand of the hg19 reference assembly. P-values
114
were not adjusted for multiple comparisons.
115
Our primary analyses were performed in all subjects, with a method used to specifically address To determine whether loci previously described in association with lung function were enriched annotated regions from the ENCODE project, and calculates an uncorrected binomial P-value.
146
Linkage disequilibrium between SNPs was estimated using the 1000 Genomes reference data in 147 SNAP (20) , the 1000 Genomes EUR reference data, or (for the calculation with the reported 148 DLC1 variant) the imputed genotypes in the African-American COPDGene samples, and 149 calculated using plink. All chromosomal positions are given using the NCBI37/hg19 assembly,
150
and alleles are referenced to the + strand. 
Supplemental Results
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Genome-wide Association Quality Control
